For instance, in a large clinical trial (ICELAND), patients with locally advanced or relapsing PCa were treated with a GnRH agonist (leuprorelin), either alone or in combination with the antiandrogen bicalutamide. Here, GNRH1 is linked to posterior cortical atrophy.